3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
12
Sarcoma
3
Neoplasm Metastasis
3
Triple Negative Breast Neoplasms
2
Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Rectal Neoplasms
1
Pleural Effusion, Malignant
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Lung Neoplasms
1
Inflammatory Breast Neoplasms
1
Hemangiosarcoma
1
Head and Neck Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Merkel Cell
1
Carcinoma, Hepatocellular
1
Carcinoma, Ductal, Breast
1
Carcinoma, Ductal
1
Advanced Non CNS Tumors
1
Adenocarcinoma
1
Interventions
Imatinib Mesylate
2
tipifarnib
1
nilotinib
1
mirdametinib
1
cabozantinib
1
binimetinib
1
Sunitinib
1
Sevoflurane
1
Propofol
1
Percutaneous Collagen Induction
1
Nitrous Oxide
1
Lidocaine
1
Glycopyrrolate
1
Dexmedetomidine
1
Aminolevulinic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neurofibromatoses
×
talimogene laherparepvec
×
Clear all
No trials found.